ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hair lotion aims to thicken thinning hair in men
Disease control Recruiting nowThis study tests a new hair lotion (Finlândia) for men with male pattern baldness. About 190 men aged 18 to 60 who already use minoxidil will receive either the new lotion or a placebo for 6 months. The main goal is to see if the lotion increases hair density on the scalp.
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated May 26, 2026 11:04 UTC
-
New foam aims to regrow hair in women – 294 join trial
Disease control Recruiting nowThis study tests whether a once-daily 5% minoxidil foam can help women with androgenetic alopecia (female pattern baldness) regrow hair. About 294 women aged 18 and older with mild to moderate hair loss will use the foam or a placebo for 24 weeks. The main goal is to measure chan…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 11:02 UTC
-
New injection showdown: can secretome beat PRP for baldness?
Disease control Recruiting nowThis study tests whether injections of secretome (a substance from stem cells) or platelet-rich plasma (PRP) can improve hair density and thickness in people with androgenetic alopecia (common pattern baldness). The trial will enroll 40 men and women aged 25-59. Participants will…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New pill could help women regrow hair – major trial underway
Disease control Recruiting nowThis study tests an experimental oral drug called VDPHL01 for women with androgenetic alopecia, a common genetic form of hair loss. About 552 women aged 18-65 with mild to moderate hair loss will receive either the drug or a placebo for 13 months. The goal is to see if the drug i…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC